ACADIA Pharmaceuticals
ACAD
$15.25
Share price
0.26%
Change (1 day)
-28.84%
Change (1 year)
Categories
ACADIA Pharmaceuticals (ACAD) - Total debt
Total debt on the balance sheet as of December 2023 : $57.2 M
According to ACADIA Pharmaceuticals's latest financial reports the company's total debt is $57.2 M. A company’s total debt is the sum of all current and non-current debts.
ACADIA Pharmaceuticals - Total debt on balance sheet (from 2003 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $57.2 M | -7.73% |
| 2022-12-31 | $62 M | -3.77% |
| 2021-12-31 | $64.43 M | 30.04% |
| 2020-12-31 | $49.54 M | 405.84% |
| 2019-12-31 | $9.79 M | |
| 2018-12-31 | $N/A | |
| 2011-12-31 | $0.03 M | -70.91% |
| 2010-12-31 | $0.11 M | -76.24% |
| 2009-12-31 | $0.46 M | -62.2% |
| 2008-12-31 | $1.22 M | -42.6% |
| 2007-12-31 | $2.13 M | -10.15% |
| 2006-12-31 | $2.37 M | 33.28% |
| 2005-12-31 | $1.78 M | -29.57% |
| 2004-12-31 | $2.53 M | -48.01% |
| 2003-12-31 | $4.86 M | -24.36% |
| 2002-12-31 | $6.43 M | 386.32% |
| 2001-12-31 | $1.32 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $33.63 B | 58,692.06% | 🇺🇸 USA |
 Pfizer PFE | $70.84 B | 123,744.07% | 🇺🇸 USA |
 Eli Lilly LLY | $26.21 B | 45,720.12% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $57.40 B | 100,256.61% | 🇺🇸 USA |
 Vanda Pharmaceuticals VNDA | $9.4 M | -83.56% | 🇺🇸 USA |
 Adamas Pharmaceuticals
ADMS | N/A | N/A | 🇺🇸 USA |